These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 35358374)
1. Coupling Lipid Nanoparticle Structure and Automated Single-Particle Composition Analysis to Design Phospholipase-Responsive Nanocarriers. Barriga HMG; Pence IJ; Holme MN; Doutch JJ; Penders J; Nele V; Thomas MR; Carroni M; Stevens MM Adv Mater; 2022 Jul; 34(26):e2200839. PubMed ID: 35358374 [TBL] [Abstract][Full Text] [Related]
2. Correlating the Structure and Gene Silencing Activity of Oligonucleotide-Loaded Lipid Nanoparticles Using Small-Angle X-ray Scattering. Hammel M; Fan Y; Sarode A; Byrnes AE; Zang N; Kou P; Nagapudi K; Leung D; Hoogenraad CC; Chen T; Yen CW; Hura GL ACS Nano; 2023 Jun; 17(12):11454-11465. PubMed ID: 37279108 [TBL] [Abstract][Full Text] [Related]
3. Chemistry of Lipid Nanoparticles for RNA Delivery. Eygeris Y; Gupta M; Kim J; Sahay G Acc Chem Res; 2022 Jan; 55(1):2-12. PubMed ID: 34850635 [TBL] [Abstract][Full Text] [Related]
4. Investigating the mechanism of action of DNA-loaded PEGylated lipid nanoparticles. Digiacomo L; Renzi S; Quagliarini E; Pozzi D; Amenitsch H; Ferri G; Pesce L; De Lorenzi V; Matteoli G; Cardarelli F; Caracciolo G Nanomedicine; 2023 Sep; 53():102697. PubMed ID: 37507061 [TBL] [Abstract][Full Text] [Related]
5. Mechanism of macromolecular structure evolution in self-assembled lipid nanoparticles for siRNA delivery. Gindy ME; DiFelice K; Kumar V; Prud'homme RK; Celano R; Haas RM; Smith JS; Boardman D Langmuir; 2014 Apr; 30(16):4613-22. PubMed ID: 24684657 [TBL] [Abstract][Full Text] [Related]
6. Impact of non-ionizable lipids and phase mixing methods on structural properties of lipid nanoparticle formulations. Pratsinis A; Fan Y; Portmann M; Hammel M; Kou P; Sarode A; Ringler P; Kovacik L; Lauer ME; Lamerz J; Hura GL; Yen CW; Keller M Int J Pharm; 2023 Apr; 637():122874. PubMed ID: 36948476 [TBL] [Abstract][Full Text] [Related]
7. Characterization of lipid nanoparticles by differential scanning calorimetry, X-ray and neutron scattering. Bunjes H; Unruh T Adv Drug Deliv Rev; 2007 Jul; 59(6):379-402. PubMed ID: 17658653 [TBL] [Abstract][Full Text] [Related]
8. Stabilization of Ostwald ripening in low molecular weight amino lipid nanoparticles for systemic delivery of siRNA therapeutics. Gindy ME; Feuston B; Glass A; Arrington L; Haas RM; Schariter J; Stirdivant SM Mol Pharm; 2014 Nov; 11(11):4143-53. PubMed ID: 25317715 [TBL] [Abstract][Full Text] [Related]
9. Assessing the heterogeneity level in lipid nanoparticles for siRNA delivery: size-based separation, compositional heterogeneity, and impact on bioperformance. Zhang J; Pei Y; Zhang H; Wang L; Arrington L; Zhang Y; Glass A; Leone AM Mol Pharm; 2013 Jan; 10(1):397-405. PubMed ID: 23210488 [TBL] [Abstract][Full Text] [Related]
10. Polydispersity characterization of lipid nanoparticles for siRNA delivery using multiple detection size-exclusion chromatography. Zhang J; Haas RM; Leone AM Anal Chem; 2012 Jul; 84(14):6088-96. PubMed ID: 22816783 [TBL] [Abstract][Full Text] [Related]
11. A QCM-D and SAXS Study of the Interaction of Functionalised Lyotropic Liquid Crystalline Lipid Nanoparticles with siRNA. Tajik-Ahmadabad B; Mechler A; Muir BW; McLean K; Hinton TM; Separovic F; Polyzos A Chembiochem; 2017 May; 18(10):921-930. PubMed ID: 28233412 [TBL] [Abstract][Full Text] [Related]
12. Lipid nanoparticle formulations for optimal RNA-based topical delivery to murine airways. Tam A; Kulkarni J; An K; Li L; Dorscheid DR; Singhera GK; Bernatchez P; Reid G; Chan K; Witzigmann D; Cullis PR; Sin DD; Lim CJ Eur J Pharm Sci; 2022 Sep; 176():106234. PubMed ID: 35688311 [TBL] [Abstract][Full Text] [Related]
13. Analysis of PEG-lipid anchor length on lipid nanoparticle pharmacokinetics and activity in a mouse model of traumatic brain injury. Waggoner LE; Miyasaki KF; Kwon EJ Biomater Sci; 2023 Jun; 11(12):4238-4253. PubMed ID: 36987922 [TBL] [Abstract][Full Text] [Related]
14. On the Formation and Morphology of Lipid Nanoparticles Containing Ionizable Cationic Lipids and siRNA. Kulkarni JA; Darjuan MM; Mercer JE; Chen S; van der Meel R; Thewalt JL; Tam YYC; Cullis PR ACS Nano; 2018 May; 12(5):4787-4795. PubMed ID: 29614232 [TBL] [Abstract][Full Text] [Related]
15. The role of lipid components in lipid nanoparticles for vaccines and gene therapy. Hald Albertsen C; Kulkarni JA; Witzigmann D; Lind M; Petersson K; Simonsen JB Adv Drug Deliv Rev; 2022 Sep; 188():114416. PubMed ID: 35787388 [TBL] [Abstract][Full Text] [Related]
16. Lipid Nanoparticles─From Liposomes to mRNA Vaccine Delivery, a Landscape of Research Diversity and Advancement. Tenchov R; Bird R; Curtze AE; Zhou Q ACS Nano; 2021 Nov; 15(11):16982-17015. PubMed ID: 34181394 [TBL] [Abstract][Full Text] [Related]